not recommended for use with DPP-4 inhibitors Common side effects : Gastrointestinal symptoms (nausea, vomiting, diarrhea) that typically diminish with continued use and proper dose titration Referral to endocrinology or obesity medicine specialists is appropriate for complex cases, including patients with multiple failed therapies, significant comorbidities, or those requiring comprehensive weight management programs
JAMA Internal Medicine , 176 (10), 14531463
A simple rule of thumb: if a website will sell you a GLP-1 without asking a single question about your health, thats not a shortcut
Overweight Individuals with Health Conditions : Adults with a BMI of 27 or higher who also have weight-related conditions such as type 2 diabetes, hypertension, or high cholesterol may be good candidates
For individuals struggling with both weight issues and depression, this could be a significant area of hope